| Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors (NCT02415153) | National Cancer Institute (NCI) | 2015-07-14 |
| Palbociclib Isethionate in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors (NCT02255461) | Pediatric Brain Tumor Consortium | 2014-12-08 |
| 18F-FDOPA PET/CT or PET/MRI in Measuring Tumors in Patients With Newly-Diagnosed or Recurrent Gliomas (NCT02175745) | Erik Mittra | 2014-12-01 |
| Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors (NCT02194452) | Sue O'Dorisio | 2013-09-01 |
| Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia (NCT01088763) | National Cancer Institute (NCI) | 2010-03-01 |
| Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors (NCT01076530) | National Cancer Institute (NCI) | 2010-02-01 |
| Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma (NCT00994500) | National Cancer Institute (NCI) | 2009-08-01 |
| ABT-888 and Temozolomide in Treating Young Patients With Recurrent or Refractory CNS Tumors (NCT00946335) | National Cancer Institute (NCI) | 2009-07-01 |
| Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment (NCT00929903) | National Cancer Institute (NCI) | 2009-06-01 |
| Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor (NCT00638898) | City of Hope Medical Center | 2007-02-26 |
| Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma (NCT00381797) | National Cancer Institute (NCI) | 2006-08-01 |
| Ispinesib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Lymphoma (NCT00363272) | National Cancer Institute (NCI) | 2006-06-01 |
| AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors (NCT00326664) | National Cancer Institute (NCI) | 2006-03-01 |
| Combination Chemotherapy in Treating Young Patients With Advanced Solid Tumors (NCT00281944) | National Cancer Institute (NCI) | 2005-09-01 |
| Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas (NCT00101270) | National Cancer Institute (NCI) | 2005-03-01 |
| Lapatinib in Treating Young Patients With Recurrent or Refractory Central Nervous System Tumors (NCT00095940) | National Cancer Institute (NCI) | 2004-10-01 |
| Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment (NCT00091182) | National Cancer Institute (NCI) | 2004-10-01 |
| Tipifarnib in Treating Young Patients With Recurrent or Progressive High-Grade Glioma, Medulloblastoma, Primitive Neuroectodermal Tumor, or Brain Stem Glioma (NCT00070525) | National Cancer Institute (NCI) | 2003-11-01 |
| Cilengitide in Treating Children With Refractory Primary Brain Tumors (NCT00063973) | National Cancer Institute (NCI) | 2003-07-01 |
| Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain Tumors (NCT00052780) | National Cancer Institute (NCI) | 2002-10-01 |
| FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or Leukemia (NCT00053963) | National Cancer Institute (NCI) | 2002-09-01 |
| Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas (NCT00012181) | National Cancer Institute (NCI) | 2001-04-01 |